Olanzapine Induced Hair Loss: A Case Report

Kuloğlu, Murat; Korkmaz, Sevda; Kilic, Nilufer; Sağlam, Sema; Gürok, Mehmet Gürkan; Atmaca, Murad

doi:10.5455/bcp.20120719020657

Cited by 13 publications

(12 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…But it is difficult to decide whether hair loss is related to these antidepressant use or not and there is no available specific method for the certain diagnosis [21]. A reliable option to definition the causal relationship is the observation of hair loss reduction or disappearance when the treatment is stopped.…”

Section: Discussionmentioning

confidence: 99%

Alopecia associated with agomelatine use: a case report

Gündoğmuş¹,

İspir²,

Karagöz³

et al. 2017

Psychiatry and Clinical Psychopharmacology

View full text Add to dashboard Cite

Drug-induced alopecia, characterized by non-scarring hair loss of scalp and body, is a rare side effect of psychotropic drugs. It has previously been reported with the different antidepressant medications, but has not been described with agomelatine. Agomelatine is an antidepressant with a novel mechanism of action and fewer side effects. Here, we report a 31-year-old male patient with diffuse hair loss induced by agomelatine use and improved by discontinuation the drug. Because antidepressant-induced hair loss is relatively rare, many clinicians may not pay attention for this side effect. As far as we know, this is the first published case report of alopecia associated with agomelatine. ARTICLE HISTORY

show abstract

Section: Discussionmentioning

confidence: 99%

Alopecia associated with agomelatine use: a case report

Gündoğmuş¹,

İspir²,

Karagöz³

et al. 2017

Psychiatry and Clinical Psychopharmacology

View full text Add to dashboard Cite

show abstract

“…There are also hair loss cases in the literature which resulted from use of antipsychotics (2,3). Among antidepressants, medication group which is most frequently associated with hair losis, is tricyclic antidepressants (4).…”

Section: Introductionmentioning

confidence: 99%

Venlafaxine induced hair loss: a case report

Demir¹

2016

Dusunen Adam

View full text Add to dashboard Cite

Venlafaxine induced hair loss: a case report Agents within antidepressants which are most commonly associated with hair loss are tricyclic antidepressants. However, hair loss side-effect due to SNRIs are limited to case reports. A 33 years old, married female patient with two children was suffering from depression and anxiety symptoms such as anhedonia, insomnia once or twice a year since her twenties. For the last 4 months, she had developed depressive mood, unwillingness, pessimism, aggressiveness, impatience, anxiousness and constant feeling of fatigue, and she visited to our clinic, because she felt that her symptoms were getting worse. She was diagnosed with recurrent type of major depression according to DSM-IV, and venlafaxine treatment was started at 75mg/day dose. At the end of second month she reported complaint of hair loss. Her laboratory findings including thyroid function tests, vitamin B-12 and D were all normal. The treatment was continued, but at the end of the 4 th month hair loss problem was intolerable. After ruling out organic reasons, it was suspected that venlafaxine might be the cause, and it was tapered down and stopped. During the first month control after drug discontinuation, hair loss was clearly decreased, and it was completely stopped at the end of the second month. Clinicians should be aware that although hair loss due to venlafaxine is a rare problem, if patients receiving venlafaxine have this complaint, it should not be overlooked. Soruna neden olabilecek diğer etkenler dışlandıktan sonra, saç dökülmesinin venlafaksine bağlı olabileceği düşünülüp, doz kademeli olarak azaltılarak kesildi. Venlafaksin kesildikten 1 ay sonra kontrole geldiğinde saç dökülmesi belirgin şekilde azalan hastanın, 2. ayın sonunda dökülmesi tamamen durmuştu. Klinisyenler nadir görülmesine karşın venlafaksinin yol açabileceği saç dökülmesi konusunda uyanık olmalı ve bu durumun atlanmaması için gerekli sorgulamanın yapılması gereklidir.

show abstract

“…1 The most related psychotropic drug class with this side effect is mood stabilizers. 2 Selective serotonin reuptake inhibitors (SSRI's) are commonly prescribed psychotropic medication due to its better overall safety and tolerability than older antidepressants 3 . It is used in conditions like major depressive disorder, obsessive com pulsive disorder, panic disorder, generalized anxiety disorder, posttraumatic stress disorder and many other psychiatric disorders 4 .…”

Section: Introductionmentioning

confidence: 99%

Pharmacist Intervention in Fluvoxamine Induced Alopecia: A Case Report in Tertiary Care Teaching Hospital

Koshy¹,

Hosur²,

Jose³

et al. 2016

IJOPP

View full text Add to dashboard Cite

Hair loss (alopecia) is an occasional side effect associated with psychotropic drugs use. Fluvoxamine is a synthetic antidepressant which acts as a selective serotonin reuptake inhibitor as well as sigma-1 receptor agonist. Psychotropic drugs are considered to cause hair loss by affecting the telogenic phase of hair follicle. Here we present a case of a 28 year old male patient reported with diffuse hair loss after administration of fluvoxamine and condition remitted after cessation of the drug. Our report suggests the possibility of developing alopecia with fluvoxamine use.

show abstract

Olanzapine Induced Hair Loss: A Case Report

Cited by 13 publications

References 13 publications

Alopecia associated with agomelatine use: a case report

Alopecia associated with agomelatine use: a case report

Venlafaxine induced hair loss: a case report

Pharmacist Intervention in Fluvoxamine Induced Alopecia: A Case Report in Tertiary Care Teaching Hospital

Contact Info

Product

Resources

About